Heritability of thromboxane A2 and prostaglandin E2 biosynthetic machinery in a spanish population

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 1, 2010, Pages 128-134

  Vila, Luis ^a   Martinez Perez, Angel ^b   Camacho, Mercedes ^a   Buil, Alfonso ^b   Alcolea, Sonia ^a   Pujol Moix, Nuria ^b   Soler, Marta ^a   Antón, Rosa ^a   Souto, Juan Carlos ^b   Fontcuberta, Jordi ^b   Soria, José Manuel ^b  

^a Laboratory of Angiology   (France)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Atherosclerosis; Gene expression; Genomics; Prostaglandins; Thrombosis; Thromboxanes

Indexed keywords

PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2; THROMBOXANE SYNTHASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SPAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ENVIRONMENT; ENZYMES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MIDDLE AGED; PHENOTYPE; PLATELET COUNT; SPAIN; THROMBOXANE A2; THROMBOXANE-A SYNTHASE; VASCULITIS; YOUNG ADULT;

EID: 73849137879     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.193219     Document Type: Article

References (37)

1. Vila L. Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med Res Rev. 2004;24:399-424.
2. Davidge ST. Prostaglandin H synthase and vascular function. Circ Res. 2001;89:650-660.
3. 2 from prostaglandin endoperoxides. Nature. 1976;261: 558-560.
4. Pawlowski NA, Kaplan G, Hamill AL, Cohn ZA, Scott WA. Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J Exp Med. 1983;158:393-412.
5. Ellis EF, Oelz O, Roberts LJ, Payne NA, Sweetman BJ, Nies AS, Oates JA. Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science. 1976;17;193: 1135-1137.
6. Hamberg M, Svensson J, Samuelsson B. Thromboxanes. a new group of biologically active compounds derived from prostaglandin endoperox-ides. Proc Natl Acad Sci U S A. 1975;72:2994-2998.
7. 2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells. Clin Exp Immunol. 1998;112:464-470.
8. 2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells. Clin Exp Immunol. 2000;120:71-78.
9. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K, Nebert DW. The P450 superfamily: update of new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993;12:1-51.
10. Wang LH, Ohashi K, Wu KK. Isolation of partial complementary DNA encoding human thromboxane synthase. Biochem Biophys Res Commun. 1991;177:286-291.
11. Griffiths R. Prostaglandins and Inflammation. In Gallin J, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. Lippincott Williams and Wilkins: Philadelphia, Pa; 1999:349-360.
12. 2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem. 1992;267:515-519.
13. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
14. Varga J, Diaz-Pérez A, Rosenbloom J, Jimenez SA. PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and II procollagen mRNAs in normal dermal fibroblasts. Biochem Biophys Res Commun. 1987;147:1282-1288.
15. Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, Iezzi A, Uchino S, Boccoli G, Saba V, Chiarelli F, Cuccurullo F, Mezzetti A. Overexpression of functionally coupled cyclooxygenase-2 and prosta-glandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation. 2001;104: 921-927.
16. Cipollone F, Iezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C, De Cesare D, De Blasis G, Muraro R, Bei R, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation. 2003;108:1070-1077.
17. Gomez-Hernandez A, Martin-Ventura JL, Sanchez-Galan E, Vidal C, Ortego M, Blanco-Colio LM, Ortega L, Tuñón J, Egido J. Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB. Atherosclerosis. 2006;187: 139-149.
18. 2 biosynthesis in vascular smooth muscle cells. J Thromb Haemostas. 2007;5:1411-1419.
19. Wang M, Lee E, Song W, Ricciotti E, Rader DJ, awson JA, Puré E, FitzGerald GA. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic an-eurysm formation. Circulation. 2008;117:1302-1309.
20. Bray PF, Mathias RA, Faraday N, Yanek LR, Fallin MD, Herrera-Galeano E, Wilson AF, Becker LC, and Becker DM. Heritability of Platelet function in families with premature coronary artery disease. J Throm Haemost. 2007;5:1617-1623.
21. Faraday N, Yanek LR, Mathias R, Herrera-Galeano JE, Vaidya D, Moy TF, Fallin MD, Wilson AF, Bray PF, Becker LC, Becker DM. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. Circulation. 2007;115: 2490-2496.
22. Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Quan H, Gertz BJ, Fitzgerald GA. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynam-ics, and vasoactive eicosanoids. J Pharmacol Exp Ther. 1999;289: 735-741.
23. McAdam BF, Castella-Lawson F, Mardini IA, Kapoor S, Lawson JA, Fitzgerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A. 1999;96:272-277.
24. Onguru O, Casey MB, Kajita S, Nakamura N, Lloyd RV. Cyclooxygen-ase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review. Endocr Pathol. 2005;16:253-277.
25. Li M, Kuo L, Stallone JN. Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. Am J Physiol Heart Circ Physiol. 2008;294:H2444-H2455.
26. Hétu PO, Riendeau D. Cyclooxygenase-2 contributes to constitutive pro-stanoid production in rat kidney and brain. Biochem J. 2005;391: 561-566.
27. 2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 1999;59:4574-4577.
28. Murakami M, Nakatani Y, Tanioka T, Kudo I. Prostaglandin E synthase. Prostaglandins Other Lipid Mediat. 2002;68-69:383-399.
29. 2 biosynthesis. J Biol Chem. 2000;275:32775-32782.
30. 2 synthases and cyclooxygenases in the brain. Am J Physiol Regul Integr Comp Physiol. 2004;287: R1155-R1163.
31. Camacho M, Lopez-Belmonte J, Vila L. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and PGI-synthase activity. Circ Res. 1998;83:353-365.
32. Soler M, Camacho M, Escudero JR, Iniguez MA, Vila L. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ Res. 2000;87:504-507.
33. 2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells. Kidney Int. 2006;70: 1935-1941.
34. Bishop-Bailey D, JA Mitchell, TD Warner. COX-2 in cardiovascular disease. Arterioscl Thromb Vasc Biol. 2006;26:956-958.
35. Gitlin JM, Trivedi DB, Langenbach R, Loftin CD. Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovasc Res. 2006;73:227-236.
36. Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, FitzGerald GA. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest. 2006;116:1391-1399.
37. Souto JC, Almasy L, Borrell M, Gari M, Martinez E, Mateo J, Stone WH, Blangero J, Fontcuberta J. Genetic determinants of hemostasis pheno-types in Spanish families. Circulation. 2000;101:1546-1551.